Vimarsana
Biggest News Aggregation in the World

Page 18 - Berkeley Lights News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Berkeley Lights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Berkeley Lights Today - Breaking & Trending Today

Cathie Wood Dumped These 7 Stocks in July - Vimarsana News

Cathie Wood Dumped These 7 Stocks in July

Published: July 29, 2022

In June, Cathie Wood’s ARK Investment Management suffered a sharp decline in assets, which was decidedly higher than most US exchange traded funds in 2022.

Source: insidermonkey.com
Related Topics:
United StatesUnited KingdomCathie ArkThomas Steyer FarallonDaina GrayboschTroy JensenSteven MahCathie Wood Ark EtfsCathie WoodAthanasios PsarofagisAsia PacificJuly Cathie WoodPaul MarshallKostas BiliourisCoinbase Global IncBaron Health Care FundBeam Therapeutics IncAlger Spectra FundCompugen LtdStratasys LtdAlger Small Cap Focus FundNumber Of Hedge Fund HoldersIntellia Therapeutics IncBerkeley Lights IncIan Wace Marshall
Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable Antimicrobial Peptide - Vimarsana News

Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable Antimicrobial Peptide

Published: July 27, 2022

/PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible...

Source: prnewswire.com
Related Topics:
United StatesAanika BiosciencesVishaal BhuyanPrnewswire Berkeley Lights IncUsing Berkeley LightBerkeley LightOptofluidic PlatformBerkeley LightsChief Executive Officer VishaalSiddhartha KadiaBerkeley Lights Platform
Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon(R) Platform - Vimarsana News

Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon(R) Platform

Published: July 26, 2022

EMERYVILLE, Calif., July 26, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon system for antibody discovery,as well as cell and gene therapy and cell line development research. Since acquiring the Beacon Platform in October 2021, Otsuka Pharmaceutical scientists have been developing significant expertise in using the Berkeley Lights technology and workflows. Specifically, the Beacon Platform has enabled them to expand their a...

Source: philippinetimes.com
Related Topics:
United StatesYue GengOtsuka PharmaceuticalsPrnewswire Berkeley Lights IncBerkeley LightsBeacon PlatformOtsuka PharmaceuticalBerkeley Lights PlatformJuly 26022 Prnewswire Berkeley LightsNc Nasdaq Bli A Leader In Digital Cell BiologyOday Announced Otsuka PharmaceuticalsA Leading Pharmaceutical CompanyAs Implemented The Use Of Berkeley Lights Beacon System For Antibody DiscoveryAs Well Cell And Gene Therapy Line Development Research Since Acquiring The Beacon Platform In October 2021Tsuka Pharmaceutical Scientists Have Been Developing Significant Expertise In Using The Berkeley Lights Technology And Workflows SpecificallyHe Beacon Platform Has Enabled Them To Expand Their Antibody Discovery Capacity Beyond Traditional Hybridoma Techniques On Top Of The ExpertiseTsuka Will Be Leveraging The Beacon Technology And Workflows For Use In Challenging Field Of Cell Gene Therapy With System ResearchHey Can Work Rapidly And Efficiently Towards New Discoveries Yue GengJh DEneral Manager And Senior Vice President Of The Platform Business At Berkeley LightsUot Otsuka Pharmaceutical And Their Scientists Area Great Example Ofa Team Fully Leveraging The Beacon Platform Capabilities In Multiple Scientific Disciplines They Have Demonstrated Themselves Asa Leader Competitive Pharma Market Through Dedication Learning Advanced Technologies Systems We Value Partnership To Research Using Our For Success Of Customers Quot About Berkeley Lights Isa Leading Digital Cell Biology Company Focused On Enabling Accelerating Rapid Development Commercialization Biotherapeutics Other Based Products Captures Deep PhenotypicNd Genotypic Information For Thousands Of Single Cells In Parallel And Can Also Deliver The Live Biology Customers Desire Form Best Our Platform Isa Fully IntegratedNd To End Solution
Berkeley Lights Announces Mehul Joshi as New Chief Financial Officer - Vimarsana News

Berkeley Lights Announces Mehul Joshi as New Chief Financial Officer

Published: July 25, 2022

/PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Mehul Joshi has been named chief financial officer...

Source: prnewswire.com
Related Topics:
United StatesGilead SciencesServices SaaResmed IncorporatedBerkeley LightBerkeley Lights PlatformLand Culture StationBerkeley Lights
Berkeley Lights to Report Second Quarter 2022 Financial Results on August 9, 2022 - Vimarsana News

Berkeley Lights to Report Second Quarter 2022 Financial Results on August 9, 2022

Published: July 21, 2022

/PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for...

Source: prnewswire.com
Related Topics:
United StatesBerkeley Lights IncBerkeley LightsBerkeley Lights Platform